Minims Phenylephrine Chlorhydrate Bausch + Lomb Ireland Limited (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Minims Phenylephrine Chlorhydrate, is an alpha‑adrenergic agonist presented as an ophthalmic preparation for ocular use. It is employed to dilate the pupil during eye examinations and to reduce conjunctival redness.

GNH USA supplies Minims Phenylephrine Chlorhydrate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Phenylephrine Hydrochloride acts on ocular alpha‑1 receptors to produce vasoconstriction and mydriasis, making it useful in several eye‑care situations.

- Mydriasis for eye examinations: provides rapid pupil dilation to facilitate fundus evaluation. - Reduction of ocular redness: constricts conjunctival vessels to lessen visible hyperemia. - Pre‑operative ocular decongestion: prepares the eye for surgical procedures by minimizing vascular engorgement.

Phenylephrine Hydrochloride may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging sensation upon instillation - Transient blurred vision - Mild headache - Temporary increase in intra‑ocular pressure - Mild allergic conjunctivitis - Redness that resolves quickly

Serious or Rare Side Effects: - Acute angle‑closure glaucoma - Severe allergic reaction (anaphylaxis) - Persistent mydriasis lasting several hours - Corneal ulceration or keratitis - Vision loss due to ischemic events - Systemic hypertension spikes in susceptible individuals

Before using Phenylephrine Hydrochloride eye drops, consider the following safety measures.

- Contraindication in narrow‑angle glaucoma: avoid use to prevent acute pressure rise. - Caution in patients with uncontrolled hypertension: monitor blood pressure. - Avoid in individuals with known hypersensitivity to phenylephrine or formulation excipients. - Do not combine with other mydriatic agents unless directed by an eye specialist. - Monitor intra‑ocular pressure in patients at risk for glaucoma. - Store at room temperature: keep in the original container, protect from light and moisture.

Phenylephrine Hydrochloride can interact with other systemic or ocular agents, influencing its safety profile.

Major Interactions (Avoid): - Systemic sympathomimetics (e.g., pseudoephedrine) – additive vasoconstrictive effect. - Other topical ocular vasoconstrictors – risk of excessive ischemia.

Moderate Interactions (Monitor Closely): - Antihypertensive medications (beta‑blockers, ACE inhibitors) – may blunt systemic blood‑pressure response. - Monoamine oxidase inhibitors (MAOIs) – potential for heightened sympathetic activity. - Tricyclic antidepressants – possible increase in systemic adrenergic effects.